赣南医学院学报2024,Vol.44Issue(5) :520-525.DOI:10.3969/j.issn.1001-5779.2024.05.016

肝硬化肌少症的发病机制研究进展

Advances in the pathogenesis of myasthenia gravis in liver cirrhosis

吴集帆 叶艳清
赣南医学院学报2024,Vol.44Issue(5) :520-525.DOI:10.3969/j.issn.1001-5779.2024.05.016

肝硬化肌少症的发病机制研究进展

Advances in the pathogenesis of myasthenia gravis in liver cirrhosis

吴集帆 1叶艳清2
扫码查看

作者信息

  • 1. 赣南医科大学第一临床医学院
  • 2. 赣南医科大学第一附属医院消化内科,江西 赣州 341000
  • 折叠

摘要

肌少症是肝硬化易被忽视的重要并发症之一,与肝硬化患者的死亡率增加和临床结局不佳有关.肝硬化肌少症的发生由多种机制共同参与,如各种分子靶点、信号通路、营养不良、代谢异常、蛋白稳态失衡、激素水平异常等.本文从肝硬化肌少症已知和可能的分子机制及原因进行综述,加深人们对肝硬化肌少症的认识与理解,为肝硬化肌少症的预防与治疗提供思路.

Abstract

Sarcopeniais is one of the important complications of cirrhosis easily overlooked.It is associated with increased mortality and poor clinical outcomes in cirrhotic patients.Multiple mechanisms are involved in the development of cirrhotic sarcopenia,such as various molecular targets,signaling channels,malnutrition,metabolic abnormalities,imbalance in protein homeostasis,abnormal hormone levels,etc.This article reviews the known and possible molecular mechanisms and causes of cirrhotic sarcopenia to deepen the knowledge and understanding of cirrhotic sarcopenia,aiming to provide some ideas for the prevention and treatment of cirrhotic sarcopenia.

关键词

肝硬化/肌少症/机制

Key words

Liver cirrhosis/Sarcopenia/Mechanism

引用本文复制引用

出版年

2024
赣南医学院学报
赣南医学院

赣南医学院学报

影响因子:0.622
ISSN:1001-5779
参考文献量2
段落导航相关论文